ReviewHuman

Eruptive Melanocytic Nevi: A Review

American journal of clinical dermatology, 2019 Oct. Burian EA, Jemec GBE.

Study type

Review

Subjects

Human participants (PubMed MeSH: Humans)

Journal

American journal of clinical dermatology

Published

2019 Oct

PubMed

PMID 31119650 ↗

DOI

10.1007/s40257-019-00444-8 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Afamelanotide →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Dysplastic Nevus SyndromeHumansImmunosuppressive AgentsNevus, PigmentedPeptides, CyclicPrecipitating FactorsRisk AssessmentSkin Neoplasmsalpha-MSH

Other papers on Afamelanotide

Randomized controlled trial · 2015

Afamelanotide for Erythropoietic Protoporphyria

Review · 2017

Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders

Journal article · 2022

Objective light exposure measurements and circadian rhythm in patients with erythropoietic protoporphyria: A case-control study

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page